Brief: Kuros Biosciences FY Loss At EUR 16.5 Mln

Kuros Biosciences AG

30/04/2018 06:04

April 30 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * IN 2018, AIMS TO CAPITALIZE ON RESTRUCTURING AS IT
EXECUTES ON
ITS RENEWED FOCUS ON ORTHOBIOLOGICS
    * FY LOSS 16.484 MILLION EUR VERSUS LOSS 19.744 MILLION EUR
YEAR
AGO

Source text for Eikon:  ID:nGNX9Z28vF 
Further company coverage:  KURN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))